Arbutus Biopharma Corp (ABUS) stock
ABUSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3081% below fair value
$4.09+0.06 (+1.49%)
Close on Nov 13, 2026Market cap $809.20MP/E 3.7Yield –
Arbutus Biopharma market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Arbutus Biopharma's market cap was $766.82M on Nov 11, 2026, against $846.52M a year earlier. Over the last 5 years it ranged from $284.20M to $1.00B, with a median of $591.68M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $766.82M | -16.9% |
| 2025 | Dec 31, 2025 | $923.30M | +49.0% |
| 2024 | Dec 31, 2024 | $619.46M | +47.8% |
| 2023 | Dec 29, 2023 | $419.24M | +17.8% |
| 2022 | Dec 30, 2022 | $355.82M | -17.0% |
| 2021 | Dec 31, 2021 | $428.93M | +42.8% |
| 2020 | Dec 31, 2020 | $300.40M | +90.1% |
| 2019 | Dec 31, 2019 | $158.04M | -25.6% |
| 2018 | Dec 31, 2018 | $212.46M | -23.6% |
| 2017 | Dec 29, 2017 | $278.01M | +106.9% |
| 2016 | Dec 30, 2016 | $134.36M | -44.7% |
| 2015 | Dec 31, 2015 | $242.84M | -28.1% |
| 2014 | Dec 31, 2014 | $337.57M | +196.1% |
| 2013 | Dec 31, 2013 | $114.01M | +89.2% |
| 2012 | Dec 31, 2012 | $60.26M | +288.6% |
| 2011 | Dec 30, 2011 | $15.51M | – |
See a number that looks wrong?